Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp, from Mapp Biopharmaceutical.
from The Medical News http://ift.tt/1D7J0Iv
from The Medical News http://ift.tt/1D7J0Iv
No comments:
Post a Comment